IGHE and allergic disease: This inconsistent efficacy and the knowledge that successful AIT is dependent on the boost of allergen-specific IgG antibodies that compete with patients ́ IgE antibodies for allergen binding, led to the first allergen-specific antibody-based approaches for allergy treatment (19, 20).